本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tempest Therapeutics Inc.

10.99
+0.96009.57%
盤後11.080.0900+0.82%19:58 EDT
成交量:8.95萬
成交額:95.75萬
市值:4,879.74萬
市盈率:-0.56
高:11.17
開:10.12
低:10.12
收:10.03
52周最高:20.67
52周最低:5.35
股本:444.02萬
流通股本:416.38萬
量比:1.66
換手率:2.15%
股息:- -
股息率:- -
每股收益(TTM):-19.4955
每股收益(LYR):-19.4955
淨資產收益率:-322.57%
總資產收益率:-81.34%
市淨率:4.99
市盈率(LYR):-0.56

資料載入中...

2021/07/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/07

重要事件披露

8-K - Current report
2021/07/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/01

重要事件披露

8-K/A [Amend] - Current report
2021/06/28

重要事件披露

8-K - Current report
2021/06/23

重要事件披露

8-K - Current report
2021/06/11

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/11

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/29

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/29

企業合併公告

425 - Prospectuses and communications, business combinations
2021/03/29

重要事件披露

8-K - Current report
2021/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals